NCT00212368已完成3 期
Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
Nobelpharma0 个研究点开始时间: 2004年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Wilson's disease(adult,infant,pregnant woman)
排除标准
- •acute hepatitis
- •malignant tumor
研究者
相似试验
已完成
3 期
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.Wilson's DiseaseNCT00212355Nobelpharma37
已完成
不适用
Crinical evaluation of zinc acetate for prevention of mucositis associated with radiotherapy in patients with head and neck cancerJPRN-UMIN000030965Kagawa university hospital Otolaryngology-Head and Neck Surgery25
已完成
不适用
Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental EnteropathyEnteropathyNCT01440608Washington University School of Medicine225
招募中
不适用
Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis in Adolescents.GingivitisNCT06671106Università degli Studi di Ferrara150
已完成
不适用
Evaluation of the Efficacy and Safety of Zinc in Viral InfectionsSARS-CoV2 InfectionNCT05212480University of Monastir460